Partner Monica Chmielewski was quoted in a Modern Healthcare article, “21st Century Cures Act driving FDA Changes,” about the effect that a landmark piece of legislation signed into law during the final month of the Obama administration is having on the FDA’s approval process.
With the passage of the act, Chmielewski said, the FDA was tasked with a somewhat onerous, but worthwhile set of responsibilities and projects. “The FDA continues to push forward to meet the requirements under the act and implement the necessary programs and changes,” she said.
(Subscription required)
People
Related News
June 6, 2025
In the News
David Rosen Comments on FDA, Compounder Conflict Over Drug Shortages
Foley & Lardner LLP partner David Rosen highlighted the U.S. Food and Drug Administration's drug shortage list in the BioSpace article, "Post-Chevron Legal Battles: Three Key Cases to Watch."
June 5, 2025
In the News
Michael Bennett and Zack Flagel Explore Pro Tennis Antitrust Battle
Foley & Lardner LLP attorneys Michael Bennett and Zack Flagel assess the antitrust litigation embroiling professional tennis in their LawInSport article, "Break(ing) Point? The Antitrust Battle that Could Transform Professional Tennis."
June 4, 2025
In the News
Foley Attorneys Explore IP Considerations for AI-Generated Logos
Foley & Lardner LLP attorneys Von Bryant, Norm Rich, and Alex Liederman authored the Bloomberg Law article, "AI-Generated Logos Require Careful Steps to Protect IP Rights."